UM Baltimore Grants Glycocept Rights to a Technology Designed to Increase the Efficacy of Therapeutic Monoclonal Antibodies
BALTIMORE, Oct. 28, 2015 (GLOBE NEWSWIRE) -- University of Maryland (UM) Ventures and Glycocept, Inc. announced today that the University of Maryland, Baltimore (UMB) has granted Glycocept worldwide, exclusive licensing rights to a UMB patent and …